A study led by researchers at Baylor College of Medicine has uncovered a new strategy that can potentially treat age-related disease and decline.
The study, published in the journal Cell Metabolism, demonstrates that shortening of telomeres – the ends of the chromosomes – impairs a class of enzymes called sirtuins, which play an important role in maintaining cell fitness by affecting many metabolic processes and repairing damaged chromosomes. The researchers showed that restoring the activity of sirtuins with a small compound stabilized telomeres and reduced DNA damage, which in turn improved liver disease in a mouse model. These studies suggest that maintaining telomere length might help sustain the regenerative capacity of cells and tissues and improve disease outcome.
“Our genetic material is tightly packed into thread-like structures called chromosomes and at the ends of the chromosomes are particular pieces of DNA called telomeres. Telomeres work like the plastic tips at the end of shoelaces; they prevent chromosomes from unraveling or sticking to each other,” said Dr. Ergun Sahin, lead investigator and assistant professor in the Huffington Center on Aging and the Department of Molecular Physiology and Biophysics at Baylor.
Telomeres also are involved in aging and disease; as an organism gets older, telomeres shorten and cells progressively deteriorate, stop dividing and die. Telomere shortening during human aging is believed to be a major underlying cause of age-related decline of stem cells – cells with the potential to develop into many different types of cells and help in the healing process in the body. Telomere shortening also affects the susceptibility of tissues to disease; however, how telomere shortening impairs regeneration and increases risk of disease is not well understood. Evidence suggests that stabilizing telomeres could prevent or slow down aging and disease. In this study, Sahin and his colleagues investigated the effect of restoring telomere length in a mouse model of liver tissue fibrosis
Telomere shortening has been associated with increased risk of organ failure and tissue fibrosis, usually in liver and lung, as cells with compromised telomeres fail to divide to replace dying cells.
Previous studies have shown that both telomeres and sirtuins contribute to aging and tissue fibrosis and seemed to interact with each other. In this study, Sahin and his colleagues investigated the molecular mechanisms that connected telomeres and sirtuins. For this, they developed a mouse model of liver disease in which the animals were genetically engineered to develop shorter, dysfunctional telomeres and age prematurely. When exposed to certain compounds, these animals quickly develop liver fibrosis – scarring of the liver that over time can lead to cirrhosis.
“In these mice, we discovered that shorter telomeres triggered a reduction in the production of sirtuins in liver and other tissues as well,” Sahin said. “Telomere shortening signaled the cell to reduce the production of sirtuins. This observation indicates that telomeres regulate sirtuins.”
Interestingly, the researchers also found that in turn, sirtuins can affect telomeres. When Sahin and his colleagues increased the activity of sirtuins by feeding mice a small molecule – nicotinamide mono mononucleotide, or NMN, an NAD+ precursor – telomeres were stabilized.
“Furthermore, feeding NAD+ precursor to the mice not only maintained telomere length but also improved liver condition in these mice,” Sahin said.
More research is needed before these findings can be translated into treatments for human conditions.
“It’s important to keep in mind that telomere length can also affect cancer growth. Having shorter telomeres would set cancer cells on a path to self-destruction, but keeping their telomeres long would likely allow them to continue proliferating,” Sahin said. “We plan to continue our investigation on the molecular mechanisms involved in the telomere-sirtuin interactions in order to better understand the benefits as well as the potential risks of telomere length manipulation in health and disease.”
The Latest on: Age-related disease
via Google News
The Latest on: Age-related disease
- This new finding may help in developing treatment for age-related macular degenerationon October 17, 2019 at 7:30 am
Thus, AKT2 inhibitors may have therapeutic potential,” said Dr Debasish Sinha, leader of the study team. It is well known that inflammation plays a key role in the pathogenesis of various age-related ...
- MetrioPharm AG: MetrioPharm AG Phase II Data in Psoriasis Show Dose-Response, Disease Modifying Activity and Outstanding Safety Profileon October 16, 2019 at 5:04 pm
MP1032 has shown comprehensive preclinical results in a wide range of age-related diseases like arthritis, neurodegenerative diseases, and inflammatory bowel disease. Oxidative stress has been ...
- Age-related frailty and the growing health burden: what can be done?on October 16, 2019 at 2:48 pm
Another diagnostic criterion involved the frailty index that sums up cumulative age-linked diseases and disabilities. Frailty assessment may also be done on the basis of the Clinical Frailty Scale ...
- Young blood may hold the key to treating age-related diseaseson October 16, 2019 at 12:42 pm
Now, scientists are examining whether certain molecules in young blood could help treat age-related diseases, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of ...
- RegenxBio gets positive interim data for eye disease treatmenton October 15, 2019 at 1:57 pm
Rockville’s RegenxBio Inc. (NASDAQ: RGNX) has more work to do before its eye disease treatment candidate can reach patients — but it’s already seeing some promise. The company’s ongoing phase 1 and ...
- 5 Diseases That Can Lead to Blindnesson October 15, 2019 at 9:56 am
The five most common diseases that can lead to vision loss or blindness: “The leading causes of blindness and low vision in the United States are primarily age-related eye diseases, says Barbara Horn, ...
- Gene therapy effective for treating wet age-related macular degeneration: Studyon October 14, 2019 at 11:16 pm
Recently developed gene therapy seems to be a promising alternative for treating one of the most common causes of blindness, wet age-related macular degeneration (AMD), claims a study ... AMD is a ...
- Young blood may hold the weapons for targeting age-related diseaseson October 13, 2019 at 5:35 pm
Chemistry matters. Join us to get the news you need. Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are ...
- Conjugate Active in Exudative Retinal Diseaseson October 13, 2019 at 3:06 pm
The therapy demonstrated beneficial effects in patients with neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME ... The design of KSI-301 addresses both durability and ...
- Eyenuk Receives NIH Grant To Expand AI Eye Screening Platform for Neurodegenerative Disease Detectionon October 11, 2019 at 10:29 am
As the population ages and grows, the number of people at risk for dementia and other forms of age-related cognitive impairment is poised to increase dramatically, with more than 130 million people ...
via Bing News